Skip to main content
. 2016 May 30;7(28):43835–43851. doi: 10.18632/oncotarget.9699

Table 1. Correlation between lncRNA RP11-838N2.4 expression and clinicopathologic characteristics in glioma patients.

Characteristics No % Median expression of lncRNA RP11-838N2.4/U6 P
Gender
 Male 31 58.5 2.21 0.729
 Female 22 41.5 2.11
Age, year
 <50 16 30.2 2.26 0.078
 ≥50 50 69.8 2.11
WHO Grade
 I/II 12 22.7 1.99 0.001**
 III/IV 41 77.3 2.24

Abbreviation: WHO=World Health Organization.

**

Statistical significance (p<0.01).